<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Partial gastrectomy and gastrointestinal reconstruction
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Partial gastrectomy and gastrointestinal reconstruction
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Partial gastrectomy and gastrointestinal reconstruction
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Pamela Hebbard, MD, FRCS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David I Soybel, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Wenliang Chen, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Aug 02, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H18417794">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastric resection is used to treat cases of benign gastric disease for which resection is indicated; to treat malignant gastric tumors, such as adenocarcinoma, where sufficient margins can be achieved; to treat selected cases of gastrointestinal stromal tumor; and to manage complications related to conservative management of lymphomas.
        </p>
        <p>
         The extent of gastric resection and type of reconstruction chosen impacts the nature of perioperative and later complications, particularly the development of postgastrectomy syndromes. In Japan and other countries where the incidence of early gastric cancer is high, function-preserving techniques, including proximal gastrectomy and pylorus-preserving gastrectomy, have been promoted. The role of these techniques in treating patients in Western countries has not been well studied given most patients are diagnosed at a late stage.
        </p>
        <p>
         The indications and techniques for partial gastric resection and reconstruction, perioperative care, and complications will be reviewed here. Total gastrectomy and reconstruction are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/15166.html" rel="external">
          "Total gastrectomy and gastrointestinal reconstruction"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465970701">
         <span class="h1">
          SURGICAL ANATOMY AND PHYSIOLOGY OF THE STOMACH
         </span>
         <span class="headingEndMark">
          —
         </span>
         The stomach is located in the left upper quadrant of the abdomen. Anteriorly, the stomach is related to the left lateral lobe of the liver, diaphragm, colon, omentum, and anterior abdominal wall  (
         <a class="graphic graphic_figure graphicRef56689" href="/z/d/graphic/56689.html" rel="external">
          figure 1
         </a>
         ). Posteriorly, the stomach is associated with the pancreas, spleen, left kidney and adrenal gland, splenic artery, and left diaphragm  (
         <a class="graphic graphic_figure graphicRef61843" href="/z/d/graphic/61843.html" rel="external">
          figure 2
         </a>
         and
         <a class="graphic graphic_figure graphicRef75897" href="/z/d/graphic/75897.html" rel="external">
          figure 3
         </a>
         ).
        </p>
        <p>
         The stomach is divided anatomically into five sections, with each section based upon histologic differences and each having a unique role in the process of digestion  (
         <a class="graphic graphic_figure graphicRef79793" href="/z/d/graphic/79793.html" rel="external">
          figure 4
         </a>
         ). These sections include [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/33.html" rel="external">
          "Physiology of gastric acid secretion"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardia
         </strong>
         – The proximal portion of the stomach adjacent to the lower esophageal sphincter. It contains mucus neck cells and endocrine cells.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fundus
         </strong>
         – The portion of the stomach that rises above the level of the cardiac opening. It contains parietal cells, chief cells, endocrine cells, and mucus neck cells.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Body
         </strong>
         – The portion of the stomach that lies between the fundus and the antrum. It contains cell types that are similar to the fundus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antrum
         </strong>
         – The distal portion of the stomach demarcated from the body of the stomach on the lesser curvature by the angular incisura. It contains pyloric glands, endocrine cells, mucus neck cells, and G cells.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pyloric sphincter
         </strong>
         – A thick muscular valve separating the antrum from the duodenum. It contains mucus neck cells and endocrine cells.
        </p>
        <p>
        </p>
        <p>
         The blood supply to the stomach is predominantly derived from the branches of the celiac artery  (
         <a class="graphic graphic_figure graphicRef56689" href="/z/d/graphic/56689.html" rel="external">
          figure 1
         </a>
         ). The left gastric artery, which is derived from the celiac artery, courses along the lesser curvature of the stomach and anastomoses with the right gastric artery, which is a branch of the common hepatic artery. The right and left gastroepiploic arteries arise from the gastroduodenal artery and splenic arteries, respectively, and anastomose along the greater curvature. The short gastric arteries arise from the splenic artery and supply the fundus of the stomach. The gastric veins (left and right) parallel the arterial supply draining into the portal vein.
        </p>
        <p>
         When entering the lesser sac through the gastrohepatic ligament, the surgeon should take care to avoid injury to the hepatic branch of the right vagus nerve  (
         <a class="graphic graphic_figure graphicRef95127" href="/z/d/graphic/95127.html" rel="external">
          figure 5
         </a>
         ), or a replaced or accessory left hepatic artery arising from the left gastric artery, which occurs in approximately 10 percent of the population  (
         <a class="graphic graphic_figure graphicRef56984" href="/z/d/graphic/56984.html" rel="external">
          figure 6
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H465972402">
         <span class="h2">
          Lymphatic drainage
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with gastric cancer, lymphadenectomy is performed in concert with the gastric resection. The lymph node stations  (
         <a class="graphic graphic_table graphicRef88420" href="/z/d/graphic/88420.html" rel="external">
          table 1
         </a>
         ), as defined by the Japanese Gastric Cancer Association, are grouped according to location  (
         <a class="graphic graphic_figure graphicRef88422" href="/z/d/graphic/88422.html" rel="external">
          figure 7
         </a>
         ) and follow the extent of potential lymph node dissection (D1 through D3) [
         <a href="#rid2">
          2
         </a>
         ]. (See
         <a class="local">
          'Lymph node dissection'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perigastric lymph nodes
         </strong>
         – Refers to lymph nodes attached directly to the stomach along the greater and lesser curvatures
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perivascular lymph nodes
         </strong>
         – Refers to lymph nodes along the gastric (left and right), gastroepiploic, hepatic (left and right), celiac, splenic, or mesenteric vessels
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Peripyloric
         </strong>
         – Refers to lymph nodes above and below the pylorus
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Peripancreatic
         </strong>
         – Refers to lymph nodes in the region of the pancreas
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Periaortic
         </strong>
         – Refers to lymph nodes in the vicinity of the aorta
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18417801">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastrectomy may be indicated in the treatment of various stomach diseases both malignant and benign or, rarely, in the management of devascularization injuries of the stomach due to trauma or other insults.
        </p>
        <p class="headingAnchor" id="H465970771">
         <span class="h2">
          Malignant tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Whether partial gastrectomy is appropriate for the management of malignant tumors of the stomach depends upon the ability to control local disease by obtaining an appropriate margin [
         <a href="#rid3">
          3
         </a>
         ]. In patients with malignant tumors, partial gastric resection and reconstruction may be indicated primarily, in combination with neoadjuvant therapy, to manage complications, or, in select circumstances, to treat tumor recurrence [
         <a href="#rid4">
          4
         </a>
         ]. The management of individual tumors for which partial gastrectomy may be indicated is discussed in detail elsewhere and includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adenocarcinoma. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrointestinal stromal tumors. (See
         <a class="medical medical_review" href="/z/d/html/7727.html" rel="external">
          "Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuroendocrine tumors. (See
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2026.html" rel="external">
          "Multiple endocrine neoplasia type 1: Management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2584.html" rel="external">
          "Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lymphoma. Surgery does not play a role in the primary treatment of most patients with gastric mucosa-associated lymphoid tissue (MALT) or non-MALT (diffuse large B cell) lymphomas, except to manage gastric perforation or bleeding not amenable to endoscopic management [
         <a href="#rid5">
          5-7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4710.html" rel="external">
          "Treatment of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT lymphoma)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465970828">
         <span class="h2">
          Benign tumors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leiomyoma is the most common benign tumor for which partial gastric resection is performed [
         <a href="#rid8">
          8
         </a>
         ]. Partial gastric resection has also been described in the diagnosis and/or treatment of less common submucosal lesions, including lipoma/adenomyoma and juvenile polyposis [
         <a href="#rid9">
          9,10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7727.html" rel="external">
          "Local treatment for gastrointestinal stromal tumors, leiomyomas, and leiomyosarcomas of the gastrointestinal tract"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465970857">
         <span class="h2">
          Ulcer disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antrectomy/distal gastrectomy may be required to manage ulcer disease but is a treatment of last resort only after conservative management, including eradication of
         <em>
          Helicobacter pylori
         </em>
         , has failed. Partial gastrectomy may also be indicated to manage complications of ulcer disease (eg, gastric outlet obstruction, bleeding, perforation) or if there is a suspicion of adenocarcinoma. (See
         <a class="medical medical_review" href="/z/d/html/8040.html" rel="external">
          "Surgical management of peptic ulcer disease"
         </a>
         .)
        </p>
        <p>
         Antrectomy/distal gastrectomy may also be necessary to remove the source of hypergastrinemia in selected patients with Zollinger-Ellison syndrome or in those with type I (not associated with multiple endocrine neoplasia [MEN]) or type II (associated with MEN-1) gastric carcinoid, with the extent of resection determined by the size and number of lesions. Patients with type III gastric (sporadic) carcinoid may require antrectomy/distal gastrectomy or total gastrectomy with extended lymph node dissection. (See
         <a class="medical medical_review" href="/z/d/html/2584.html" rel="external">
          "Management and prognosis of the Zollinger-Ellison syndrome (gastrinoma)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H133456307">
         <span class="h2">
          Bariatric or metabolic surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastric resection, in the form of sleeve gastrectomy, has been used in the management of obesity. (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465970835">
         <span class="h2">
          Trauma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastric resection may be necessary to manage significant injuries to the stomach. Because the stomach is well vascularized, resection is typically limited to the removal of devitalized tissue. (See
         <a class="medical medical_review" href="/z/d/html/15700.html" rel="external">
          "Traumatic gastrointestinal injury in the adult patient"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18417808">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Contraindications to abdominal surgery, in general, include systemic comorbidities that preclude safe administration of anesthesia. (See
         <a class="local">
          'Medical risk assessment'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2097588684">
         <span class="h2">
          Contraindications for patients with ulcer disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antrectomy for ulcer disease should not be performed if pyloric inflammation prevents safe dissection and preservation of surrounding structures (eg, portal triad, pancreas). Surgical bypass in the form of a gastroenterostomy may be a better option. Patients with recurrent, severe, and/or unusual disease (significant duodenal ulceration) should be screened for gastrinoma prior to surgical intervention. (See
         <a class="medical medical_review" href="/z/d/html/2627.html" rel="external">
          "Zollinger-Ellison syndrome (gastrinoma): Clinical manifestations and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H182342377">
         <span class="h2">
          Contraindications for patients with malignant disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ability to offer partial gastrectomy for malignant disease will depend upon the type of tumor, the extent of local disease, the ability to achieve appropriate surgical margins, and the presence of metastatic disease.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most surgeons would treat proximally placed malignant adenocarcinoma of the stomach with a total gastrectomy rather than a proximal subtotal gastrectomy. The exception is early gastric cancer (cT1), which can be treated with a function-preserving proximal gastrectomy. (See
         <a class="local">
          'Proximal gastrectomy'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An important contraindication to partial gastrectomy is presumed or proven hereditary diffuse gastric cancer (HDGC). Total gastrectomy with intraoperative mucosal assessment to ensure negative proximal and distal margins for gastric tissue is a more appropriate treatment for most patients with HDGC. (See
         <a class="medical medical_review" href="/z/d/html/8041.html" rel="external">
          "Surgical management of hereditary diffuse gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Gastrectomy cannot be justified in patients with metastatic adenocarcinoma of the stomach unless complications such as obstruction, bleeding, or perforation cannot be managed using other means (see
         <a class="medical medical_review" href="/z/d/html/2521.html" rel="external">
          "Local palliation for advanced gastric cancer"
         </a>
         ). For incurable advanced gastric cancer, chemotherapy is the standard of care. In a randomized trial (REGATTA), gastrectomy followed by chemotherapy did not show any survival benefit compared with chemotherapy alone [
         <a href="#rid11">
          11
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2473.html" rel="external">
          "Initial systemic therapy for locally advanced unresectable and metastatic esophageal and gastric cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with metastatic gastrointestinal stromal tumors should be managed by a multidisciplinary team, including surgery and medical oncology. Resection should be reserved for patients with complications or those showing minimal response of the symptomatic primary tumor to targeted therapies such as
         <a class="drug drug_general" data-topicid="8961" href="/z/d/drug information/8961.html" rel="external">
          imatinib
         </a>
         . (See
         <a class="medical medical_review" href="/z/d/html/7730.html" rel="external">
          "Adjuvant and neoadjuvant therapy for gastrointestinal stromal tumors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465972987">
         <span class="h1">
          TUMOR STAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients undergoing partial gastric resection for malignancy should undergo preoperative staging to the extent that is possible, including computed tomography (CT) of the abdomen, or endoscopic ultrasound, to evaluate the extent of locoregional disease and the presence of metastatic disease, which may contraindicate the resection. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Staging evaluation'
         </a>
         .)
        </p>
        <p>
         Staging laparoscopy is indicated for many patients with gastric adenocarcinoma [
         <a href="#rid12">
          12,13
         </a>
         ]; however, the selection of patients who need staging laparoscopy is controversial. Most experts recommend staging laparoscopy for patients who have locally advanced disease (T3 or T4), have nodal metastasis (N+), or may require multivisceral resection [
         <a href="#rid14">
          14,15
         </a>
         ].
        </p>
        <p>
         The laparoscopy may be performed as a standalone procedure or just prior to the planned gastrectomy. As neoadjuvant chemotherapy becomes more commonly used in gastric cancer, diagnostic laparoscopy is increasingly performed as a standalone procedure prior to the initiation of chemotherapy. This timing allows all involved to have information regarding the curability of the tumor prior to embarking on a treatment plan. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Staging laparoscopy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971156">
         <span class="h1">
          PREOPERATIVE PREPARATION
         </span>
        </p>
        <p class="headingAnchor" id="H133456095">
         <span class="h2">
          Medical risk assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The preoperative assessment prior to gastric resection should identify the presence of medical comorbidities. Most gastric resections are performed under elective circumstances for which there is adequate time for risk assessment and optimization of the patient's medical status. Preoperative medical assessment is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">
          "Evaluation of cardiac risk prior to noncardiac surgery"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">
          "Evaluation of perioperative pulmonary risk"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4816.html" rel="external">
          "Preoperative medical evaluation of the healthy adult patient"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971164">
         <span class="h2">
          Antibiotic prophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antibiotic prophylaxis is recommended for procedures that enter into the lumen of the gastrointestinal tract. Appropriate antibiotic choices for gastrectomy are given in the table  (
         <a class="graphic graphic_table graphicRef65369" href="/z/d/graphic/65369.html" rel="external">
          table 2
         </a>
         ). In addition, patients who have either a higher risk of potential colon injury or could potentially require en bloc resection of the colon should receive additional antibiotic prophylaxis against colonic flora (eg,
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13984.html" rel="external">
          "Antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971172">
         <span class="h2">
          Thromboprophylaxis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thromboprophylaxis should be administered according the patient's risk for thromboembolism  (
         <a class="graphic graphic_table graphicRef83739" href="/z/d/graphic/83739.html" rel="external">
          table 3
         </a>
         ). Patients undergoing partial gastrectomy for malignancy are at moderate-to-high risk for thromboembolism, and pharmacologic prophylaxis is recommended. For all patients, we use intermittent pneumatic compression, which should be placed prior to induction of anesthesia and continued until the patient is ambulatory. (See
         <a class="medical medical_review" href="/z/d/html/1339.html" rel="external">
          "Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971271">
         <span class="h1">
          GENERAL CONSIDERATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3724162181">
         <span class="h2">
          Anesthesia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastrectomy is performed under general anesthesia. For patients undergoing upper abdominal surgery, a transversus abdominis plane block or thoracic epidural anesthesia may simplify postoperative pain management and allow early postoperative mobilization, which may expedite the return of gastrointestinal function. They are a part of the enhanced recovery after surgery (ERAS) pathway [
         <a href="#rid16">
          16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/121447.html" rel="external">
          "Abdominal nerve block techniques", section on 'Transversus abdominis plane (TAP) blocks'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/89518.html" rel="external">
          "Epidural and combined spinal-epidural anesthesia: Techniques"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971346">
         <span class="h2">
          Open versus laparoscopic partial gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The choice between an open surgical versus laparoscopic approach to partial gastric resection depends upon the indication for surgery, the experience of the operator, and the preferences of the surgeon and patient. As with most procedures performed laparoscopically, the operating surgeon should have sufficient experience with the open procedure and should be able to perform a comparable anatomic dissection and reconstruction using laparoscopic techniques, particularly when managing malignancies.
        </p>
        <p>
         Laparoscopic partial gastrectomy has been described for many indications. A laparoscopic approach may be most feasible for limited gastric resections that require minimal dissection, such as with wedge or sleeve resection for benign indications or gastrointestinal stromal tumor [
         <a href="#rid17">
          17
         </a>
         ]; however, the laparoscopic approach has also been used for resecting invasive cancers [
         <a href="#rid18">
          18
         </a>
         ]. The feasibility and oncologic safety of laparoscopic partial gastrectomy for both early and locally advanced gastric cancer has been demonstrated by many randomized trials from Asia, and a few from Europe. (See
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer", section on 'Eastern versus Western experience'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer", section on 'Outcomes'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465973281">
         <span class="h2">
          Incision and exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The patient should be positioned supine. For open gastrectomy, a midline abdominal approach is typically used. A self-retaining retractor helps to retract the liver and intestinal contents, facilitating exposure. (See
         <a class="medical medical_review" href="/z/d/html/2.html" rel="external">
          "Incisions for open abdominal surgery", section on 'Midline incision'
         </a>
         .)
        </p>
        <p>
         The techniques of laparoscopic gastrectomy for cancer are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer", section on 'Surgical techniques'
         </a>
         .)
        </p>
        <p>
         Prior to initiating the dissection (open or laparoscopic), the abdominal cavity, including the peritoneal surfaces, should be thoroughly explored to evaluate for any metastatic disease. The extent of locoregional disease should also be assessed.
        </p>
        <p class="headingAnchor" id="H31757899">
         <span class="h2">
          Extent of resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Partial gastrectomy implies that only a part of the stomach is resected. The extent of resection depends on the location and size of the lesion, whether the lesion is benign or malignant, and for malignant lesions, whether an adequate proximal or distal margin can be achieved. When an adequate proximal gastric margin cannot be assured, a total gastrectomy is required.
        </p>
        <p>
         Total gastrectomy refers to removal of the entire stomach, including the gastroesophageal junction and pylorus. Total gastrectomy is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/15166.html" rel="external">
          "Total gastrectomy and gastrointestinal reconstruction"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971613">
         <span class="h3">
          Optimal surgical margin
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients undergoing potentially curative surgery for gastric malignancy, a tumor-free resection margin (R0) on pathologic examination is the goal of resection. A positive margin (R1) is associated with worse five-year survival (hazard ratio 2.06, 95% CI 1.61-2.65) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         To achieve an R0 resection, intraoperative frozen sections of the proximal and distal margins should be obtained in all patients undergoing potentially curative surgery. Based upon the results of these frozen sections, a wider excision may be necessary, as re-excision of a positive margin does improve the prognosis for some patients with gastric cancer [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         Because gastric cancer, especially the diffuse type, has a propensity for intramural spread, the intraoperative frozen section may not be completely reliable [
         <a href="#rid20">
          20
         </a>
         ]. Thus, a gross safety margin around the tumor is obtained to ensure negative final margins. The optimal gross margin of resection remains debated. Currently, the following has been proposed in Asian guidelines [
         <a href="#rid2">
          2,21,22
         </a>
         ] and accepted by Western surgeons [
         <a href="#rid12">
          12
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          For early gastric cancer (T1)
         </strong>
         – A proximal margin of at least 2 cm.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          For non-early gastric cancer (T2 or above)
         </strong>
         – A proximal margin of at least 3 cm for tumors with an expansive growth pattern and at least 5 cm for tumors with an infiltrative growth pattern.
        </p>
        <p>
        </p>
        <p>
         Margins for lymphoma and gastrointestinal stromal tumors (GISTs) need not be as extensive (1 to 2 cm), although there is no agreement on specific size of adequate margins. The use of intraoperative frozen section for these lesions is not well described.
        </p>
        <p class="headingAnchor" id="H465971629">
         <span class="h3">
          Lymph node dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Japanese classification defines the level of lymph node dissection  (
         <a class="graphic graphic_table graphicRef88420" href="/z/d/graphic/88420.html" rel="external">
          table 1
         </a>
         ) by the stations of lymph nodes removed for each procedure (eg, total gastrectomy, distal gastrectomy)  (
         <a class="graphic graphic_figure graphicRef88422" href="/z/d/graphic/88422.html" rel="external">
          figure 7
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. We find it more practical to use a broader classification that defines the extent of lymph node dissection according to the relationship of the nodes to the segment of stomach to be removed, as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          D0
         </strong>
         – Refers to an incomplete D1 lymph node dissection or no formal lymph node dissection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          D1
         </strong>
         – Removal of lymph node basins directly related to the segment of stomach removed (ie, perigastric nodes). A D1 lymph node dissection is the minimal lymphadenectomy required of an oncologic gastric resection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          D2 or D1+
         </strong>
         – Removal of D1 lymph node basins
         <strong>
          and
         </strong>
         lymph node basins along major named neurovascular arcades supplying that region of the stomach (eg, celiac, left gastric, hepatic, and splenic arteries).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          D3
         </strong>
         – Removal of D2 lymph node basins
         <strong>
          and
         </strong>
         para-aortic lymph nodes.
        </p>
        <p>
        </p>
        <p>
         The extent of lymph node dissection needed during gastric resection for gastric adenocarcinoma is somewhat controversial. Treatment guidelines published by the National Comprehensive Cancer Network, Cancer Care Ontario, and European Society of Surgical Oncology recommend that D2 lymph node dissection is preferred over a lesser (D1) or greater (D3) dissection [
         <a href="#rid12">
          12,13
         </a>
         ]. A D2 lymph node dissection is the standard approach to gastric cancer surgery in the East (eg, Japan, China, and Korea) [
         <a href="#rid2">
          2,21,22
         </a>
         ]. However, in view of the higher reported rates of operative mortality in earlier randomized trials when more extensive dissection is performed, this recommendation should be tempered by where and by whom the operation is being performed (ie, D2 lymphadenectomy should be performed at high-volume centers by experienced oncologic surgeons). (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Extent of lymph node dissection'
         </a>
         .)
        </p>
        <p>
         For patients with GISTs, no effort is made to perform an extended lymph node dissection because lymph node involvement is rare. For patients with neuroendocrine tumors, the extent of the lymph node dissection will depend on the type of gastric neuroendocrine tumor. (See
         <a class="medical medical_review" href="/z/d/html/2615.html" rel="external">
          "Staging, treatment, and post-treatment surveillance of non-metastatic, well-differentiated gastrointestinal tract neuroendocrine (carcinoid) tumors", section on 'Stomach'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1209450191">
         <span class="h4">
          Sentinel lymph node dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although sentinel lymph node dissection is a well-established procedure for breast cancer and melanoma worldwide, its use in gastric cancer is limited to Eastern surgeons [
         <a href="#rid23">
          23,24
         </a>
         ]. In Japan, sentinel lymph node dissection is indicated for cT1-2N0M0 patients undergoing gastrectomy [
         <a href="#rid25">
          25
         </a>
         ]. If all sentinel nodes are negative, a function-preserving partial gastrectomy is performed without additional lymphadenectomy (termed laparoscopic sentinel node navigation surgery). If any of the sentinel nodes are positive, a standard radical gastrectomy (subtotal or total) with a D2 lymph node dissection is performed [
         <a href="#rid26">
          26
         </a>
         ]. Surgeons should have pause before adopting this strategy in a lower volume Western practice, where case volumes, technical experience, and pathology experience might introduce suboptimal results [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Technical issues need to be resolved before sentinel lymph node dissection is accurate enough to be routinely applied [
         <a href="#rid24">
          24,28
         </a>
         ]. The false negative rate was unexpectedly high (46 percent) in the initial trial of 440 patients (JCOG 0302) [
         <a href="#rid29">
          29
         </a>
         ]. A subsequent trial performed by surgeons more experienced with the technique reported a much lower false negative rate of 7 percent [
         <a href="#rid30">
          30
         </a>
         ]. A larger trial (SENORITA) of 550 patients with early gastric cancer reported similar rates and severity of complications following laparoscopic sentinel node navigation surgery versus laparoscopic standard gastrectomy with lymph node dissection; long-term oncologic outcomes are pending [
         <a href="#rid31">
          31
         </a>
         ]. Proponents of laparoscopic sentinel node navigation surgery, which is built upon sentinel lymph node dissection, believe that it improves the patient's quality of life by preserving the stomach [
         <a href="#rid32">
          32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Sentinel lymph node biopsy for early gastric cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18417822">
         <span class="h1">
          RESECTION TECHNIQUES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The term "partial gastrectomy" is broad and encompasses essentially any procedure that does not remove the entire stomach. Partial gastrectomy can be proximal or distal. Distal gastrectomy can be performed to remove only the antrum, the distal two-thirds of the stomach, the distal four-fifths, or nearly the entire stomach as a subtotal gastrectomy. Other types of gastrectomy include wedge resection, mucosal/sleeve resection, proximal gastrectomy, and pylorus-preserving segmental gastrectomy.
        </p>
        <p>
         The type and extent of gastric resection is determined by the location, nature, and extent of disease  (
         <a class="graphic graphic_algorithm graphicRef141463" href="/z/d/graphic/141463.html" rel="external">
          algorithm 1
         </a>
         ). Each technique has defined indications and specific, although sometimes overlapping, reconstructive options.
        </p>
        <p>
         The options for partial gastric resection are listed. Each of these techniques is briefly reviewed below.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Local excision/wedge resection
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Benign tumor excision
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Traumatic injury to the stomach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gastrointestinal stromal tumors amenable to wedge resection with appropriate 1 to 2 cm gross margins
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sleeve (tube) gastrectomy
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Management of obesity (bariatric or metabolic surgery)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antrectomy/distal gastrectomy
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Malignant tumor in the distal (lower two-thirds) of the stomach
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Refractory peptic ulcer disease or ulcer disease associated with neuroendocrine tumors
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Traumatic injury
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Proximal gastrectomy (a type of function-preserving gastrectomy)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early gastric cancer of the proximal (upper one-third) of the stomach not amenable to endoscopic resection
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Traumatic injury
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pylorus-preserving gastrectomy (a type of function-preserving gastrectomy)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early gastric cancer of the middle third of the stomach
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subtotal gastrectomy
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Standard gastric resection for non-early gastric cancer (in lieu of total gastrectomy when adequate proximal margin can be achieved)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465972930">
         <span class="h2">
          Local excision/wedge resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal of wedge resection is to obtain an appropriate margin without significant narrowing of the stomach. Care must be taken near the gastroesophageal junction or the pylorus to avoid this problem. To perform local excision/wedge resection, the area of interest is identified, and a gastrointestinal stapler can be fired once across the stomach margin or twice to remove a triangular wedge of gastric tissue.
        </p>
        <p class="headingAnchor" id="H465972923">
         <span class="h2">
          Sleeve gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sleeve gastrectomy is a type of partial gastrectomy in which the majority of the greater curvature of the stomach is removed using gastric staplers, creating a tubular stomach. It is used almost exclusively as a bariatric procedure. (See
         <a class="medical medical_review" href="/z/d/html/109435.html" rel="external">
          "Laparoscopic sleeve gastrectomy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465972139">
         <span class="h2">
          Antrectomy/distal subtotal gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Antrectomy is used to treat patients with refractory peptic ulcer disease, neuroendocrine tumors, or gastric adenocarcinoma. When performed for distal (lower two-thirds) gastric adenocarcinoma, antrectomy/distal gastrectomy includes resection of associated lymph node basins for adenocarcinoma. (See
         <a class="local">
          'Lymph node dissection'
         </a>
         above.)
        </p>
        <p>
         To perform antrectomy/distal subtotal gastrectomy  (
         <a class="graphic graphic_figure graphicRef89669" href="/z/d/graphic/89669.html" rel="external">
          figure 8
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify the proximal resection margin. The incisura is generally recognized as the proximal extent of resection in an antrectomy. However, if needed, carry the proximal dissection superior to the incisura on the lesser curvature, and superior to the confluence of the gastroepiploic vessels on the greater curvature to obtain a sufficient margin. (See
         <a class="local">
          'Optimal surgical margin'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mobilize the greater omentum  (
         <a class="graphic graphic_figure graphicRef75897" href="/z/d/graphic/75897.html" rel="external">
          figure 3
         </a>
         ) from the transverse colon to remove it with the specimen for tumor resection. The extent of omentectomy is determined by the proximal extent of the gastric resection. The omentum can be left in situ in the case of antrectomy for benign disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identify the pylorus. Ligate and divide the right gastric and gastroepiploic vessels at the pylorus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skeletonize and transect the duodenum just distal to the pylorus using a linear stapler. Care should be taken to avoid injury to the structures of the portal triad.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some surgeons oversew the duodenal stump using a running, permanent suture (eg, 3-0 Prolene) on a noncutting needle.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Carry the dissection cephalad along the greater and lesser curves of the stomach. For adenocarcinoma, the lesser omentum (gastrohepatic ligament) should be harvested with the specimen provided there is not a variant hepatic artery  (
         <a class="graphic graphic_figure graphicRef56984" href="/z/d/graphic/56984.html" rel="external">
          figure 6
         </a>
         ) coursing through this region. For patients with benign disease, harvest the greater curve of the stomach just outside the gastroepiploic arcade. In some partial gastrectomies, the left gastric pedicle needs to be divided to achieve adequate proximal margin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For a subtotal gastrectomy, the distal left gastroepiploic arcade and some of the short gastric vessels will need to be ligated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transect at the proximal stomach margin using a linear gastrointestinal stapler.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients requiring a D2 nodal dissection, send the named nodal basins along the vascular arcades of the stomach as separate, labeled specimens for pathologic examination.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18417843">
         <span class="h2">
          Function-preserving partial gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Function-preserving techniques for partial gastrectomy have been introduced by Japanese surgeons as a means to limit or avoid syndromes that result from altered anatomy and/or physiology following traditional methods of gastric resection and reconstruction (ie, postgastrectomy syndromes). However, it is only performed in highly specialized centers in East Asian countries and is not considered a standard operation in the rest of the world. Surgeons should not attempt to perform these operations without prior in-depth knowledge and training.
        </p>
        <p>
         Function-preserving techniques are only applicable to early gastric cancers (cT1) that are either not feasible for endoscopic resection or are not completely removed by endoscopic resection. These gastrectomies are performed with a D1 or D1+ lymphadenectomy. Non-early gastric cancers (cT2-4 or N+) should be treated with a standard gastrectomy, which removes at least two-thirds of the stomach, along with a D2 node dissection that is standard in the Japanese literature [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The most frequently performed function-sparing resection procedures in the world are proximal gastrectomy for carcinoma of the upper stomach and pylorus-sparing gastrectomy (PPG) for carcinoma of the middle third of the stomach [
         <a href="#rid33">
          33
         </a>
         ]. Neither is frequently performed in Western countries, where most gastric cancers are diagnosed in an advanced stage.
        </p>
        <p class="headingAnchor" id="H129528007">
         <span class="h3">
          Proximal gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Proximal gastrectomy resects the cardia and upper portion of the corpus, but more than half of the stomach remains  (
         <a class="graphic graphic_figure graphicRef89210" href="/z/d/graphic/89210.html" rel="external">
          figure 9
         </a>
         ). It is an option for early gastric cancer in the proximal (upper third) of the stomach that does not invade the gastroesophageal junction. Studies from the East have demonstrated its oncologic safety compared with standard gastrectomy with D2 lymphadenectomy [
         <a href="#rid34">
          34,35
         </a>
         ].
        </p>
        <p>
         The alternative to proximal gastrectomy is a total gastrectomy  (
         <a class="graphic graphic_figure graphicRef61753" href="/z/d/graphic/61753.html" rel="external">
          figure 10
         </a>
         ). Compared with total gastrectomy, proximal gastrectomy may have nutritional benefits [
         <a href="#rid35">
          35,36
         </a>
         ] but a higher incidence of bile reflux and anastomotic stenosis [
         <a href="#rid34">
          34,35,37
         </a>
         ]. The exact balance between the advantages and disadvantages of proximal gastrectomy lies in its reconstruction [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Esophagogastrostomy
         </strong>
         – Esophagogastrostomy is the simplest and most physiologic reconstruction after proximal gastrectomy, which also makes it easy to surveil the gastric remnant endoscopically. The major disadvantage of esophagogastrostomy is bile reflux. Several anti-reflux modifications have been proposed, including gastric tube [
         <a href="#rid39">
          39
         </a>
         ], double-flap reconstruction [
         <a href="#rid40">
          40,41
         </a>
         ], and side overlap esophagogastrostomy with fundoplication by Yamashita [
         <a href="#rid42">
          42,43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Jejunal interposition
         </strong>
         – Jejunal interposition positions an 8 to 15 cm long pedicled loop of proximal jejunum between the esophagus and the gastric remnant. Compared with esophagogastrostomy, jejunal interposition decreases reflux but increases operative time and length of hospital stay [
         <a href="#rid44">
          44
         </a>
         ]. Additionally, residual food is another problem for jejunal interposition [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Double-tract reconstruction
         </strong>
         – During double-tract reconstruction after proximal gastrectomy, the jejunum is divided approximately 15 cm distal to the ligament of Treitz. The distal limb is anastomosed to the esophagus. A side-to-side gastrojejunostomy with the remnant stomach is performed 15 cm below the esophagojejunostomy. Finally a jejunojejunostomy is performed approximately 25 cm below the gastrojejunostomy to restore bowel continuity  (
         <a class="graphic graphic_figure graphicRef120590" href="/z/d/graphic/120590.html" rel="external">
          figure 11
         </a>
         ). In a meta-analysis of one trial and 13 nonrandomized studies comparing proximal gastrectomy with double-tract reconstruction with total gastrectomy, the former was associated with superior nutritional outcomes, but oncologic equivalency could not be assessed due to potential selection bias against total gastrectomy [
         <a href="#rid45">
          45
         </a>
         ]. The randomized trial reported very few tumor recurrences [
         <a href="#rid46">
          46
         </a>
         ]. The KLASS-05 trial also found laparoscopic proximal gastrectomy with double-tract reconstruction and laparoscopic gastrectomy comparable in perioperative outcomes [
         <a href="#rid47">
          47
         </a>
         ]. Long-term outcomes are not yet reported.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18417850">
         <span class="h3">
          Pylorus-preserving gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         PPG, which resects a portion of the stomach but leaves the pylorus intact  (
         <a class="graphic graphic_figure graphicRef89211" href="/z/d/graphic/89211.html" rel="external">
          figure 12
         </a>
         ), was originally developed as a treatment approach for gastric ulcer surgery as a means to improve quality of life and avoid postgastrectomy syndromes. This technique has been championed for patients with early gastric cancer in the middle third of the stomach with the tumor &gt;4 cm from the pylorus [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         A 2020 systematic review and meta-analysis of 21 nonrandomized comparative studies found oncologic equivalence between PPG and distal gastrectomy for early gastric cancer [
         <a href="#rid48">
          48
         </a>
         ]. The KLASS-04 trial, which directly compared the two, has not reported long-term outcomes [
         <a href="#rid49">
          49
         </a>
         ]. The safety and appropriateness of this surgery has not been studied in low-incidence populations for early gastric cancer, such as in North America.
        </p>
        <p>
         Pylorus preservation can reduce dumping syndrome and bile regurgitation, which improves nutritional status and quality of life [
         <a href="#rid33">
          33,48
         </a>
         ]. It also increases the risk of delayed gastric emptying, which can be countered by preserving the pyloric branches of the vagal nerve [
         <a href="#rid49">
          49
         </a>
         ]. (See
         <a class="local">
          'Preservation of the vagus nerves'
         </a>
         below.)
        </p>
        <p>
         To perform PPG:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Following omentectomy, harvest the lymph nodes along the right gastroepiploic vessels.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Divide the right gastroepiploic arcade distal to the infrapyloric artery and carry the dissection along the greater curve of the stomach.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Harvest the left gastroepiploic vessels with the station 4sb lymph nodes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Harvest the lymph nodes of the lesser curve and preserve the hepatic and pyloric branches of the vagus nerves and right gastric vessels.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Remove the distal stomach with station 7, 8, 9, and 11p lymph nodes, preserving 3 cm of antrum and the pylorus.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Harvest the left gastric vessels and transect the stomach proximally with a 2 cm margin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Perform an end-to-end anastomosis of the proximal to distal gastric remnants using a full-thickness single-layer suture (eg, Gambee suture  (
         <a class="graphic graphic_figure graphicRef90069" href="/z/d/graphic/90069.html" rel="external">
          figure 13
         </a>
         )).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18417857">
         <span class="h3">
          Preservation of the vagus nerves
         </span>
         <span class="headingEndMark">
          —
         </span>
         Traditional resection techniques for gastric adenocarcinoma have not emphasized preservation of the vagus nerves, but this practice is supported by Eastern surgeons who treat patients with early gastric cancer and can be performed in conjunction with a D1 or D2 lymphadenectomy. Preserving the hepatic branch of the anterior vagus nerve and celiac branch of the posterior vagus nerve decreases the incidence of postoperative diarrhea and postgastrectomy gallstone formation [
         <a href="#rid50">
          50
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/15166.html" rel="external">
          "Total gastrectomy and gastrointestinal reconstruction", section on 'Vagus nerve preservation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2729095835">
         <span class="h2">
          Subtotal gastrectomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with non-early gastric cancer (cT2-4 or N+), the standard gastric resection is either a subtotal gastrectomy or a total gastrectomy, both with a D2 lymphadenectomy. The choice is dependent on whether an adequate proximal gastric margin is achievable with a subtotal gastrectomy; if not, total gastrectomy is performed. (See
         <a class="local">
          'Optimal surgical margin'
         </a>
         above.)
        </p>
        <p>
         From an oncologic standpoint, a total gastrectomy has no advantage over subtotal gastrectomy for distal tumor when an adequate proximal margin can be achieved [
         <a href="#rid51">
          51
         </a>
         ]. Whether subtotal gastrectomy reduces morbidities compared with total gastrectomy is uncertain. A meta-analysis of six trials found that subtotal gastrectomy reduced anastomotic leaks, but not overall morbidities compared with total gastrectomy [
         <a href="#rid52">
          52
         </a>
         ]. A second meta-analysis of four trials and seven nonrandomized comparative studies associated subtotal gastrectomy with lower rate of overall postoperative complications, anastomosis leakage, wound complications, peritoneal abscesses, and mortality [
         <a href="#rid53">
          53
         </a>
         ]. A long-term study found that subtotal gastrectomy improves quality of life in the first five years after surgery [
         <a href="#rid54">
          54
         </a>
         ]. After that, any advantage over total gastrectomy diminishes.
        </p>
        <p class="headingAnchor" id="H182357342">
         <span class="h1">
          GASTROINTESTINAL RECONSTRUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reconstructive procedures can be broadly thought of as those that preserve duodenal continuity, those that preserve jejunal continuity, those that preserve both, and those that incorporate some form of pouch reconstruction. Duodenal continuity is important for preventing loss of fat-soluble vitamins, while jejunal continuity is important for preventing retrograde flow of jejunal contents, which can occur because transection of the jejunum interrupts the electrical activity normally initiated by the duodenal pacemaker, thus impairing antegrade peristalsis.
        </p>
        <p>
         Ideally, gastric reconstruction would avoid adverse consequences related to the loss of stomach tissue and function (ie, postgastrectomy syndromes), but each type of reconstruction is associated with, at a minimum, some degree of dumping (early or late) since the pylorus is typically removed (except for pylorus-preserving gastrectomy). The characteristics and postgastrectomy syndromes associated with each of these reconstructions are given in the table  (
         <a class="graphic graphic_table graphicRef89212" href="/z/d/graphic/89212.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p>
         The most common gastric reconstructive procedures following partial (typically distal) gastrectomy are the Billroth I, Billroth II, and Roux-en-Y reconstructions. Roux-en-Y reconstruction is most performed worldwide, with Billroth II being an alternative. Billroth I is primarily performed in Asia [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H465971376">
         <span class="h2">
          Billroth I
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Billroth I reconstruction  (
         <a class="graphic graphic_figure graphicRef60974" href="/z/d/graphic/60974.html" rel="external">
          figure 14
         </a>
         ) preserves duodenal and jejunal continuity by anastomosing the remnant stomach to the duodenal stump in a primary end-to-end fashion. Billroth I reconstruction is the preferred method of reconstruction when the proximal gastric remnant and the duodenal stump can be approximated without tension, which is generally possible only after antrectomy.
        </p>
        <p>
         The most common postgastrectomy syndrome  (
         <a class="graphic graphic_table graphicRef89212" href="/z/d/graphic/89212.html" rel="external">
          table 4
         </a>
         ) associated with Billroth I reconstruction is reflux of biliary contents retrograde into the stomach, causing alkaline gastritis. If the residual gastric remnant is small or nonfunctional, there will likely be some degree of dumping. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971411">
         <span class="h2">
          Billroth II
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Billroth II reconstruction  (
         <a class="graphic graphic_figure graphicRef60974" href="/z/d/graphic/60974.html" rel="external">
          figure 14
         </a>
         ) anastomoses the remnant stomach to the proximal jejunum in an end-to-side fashion. This reconstruction preserves jejunal but not duodenal continuity and is used when a Billroth I reconstruction is not possible, such as with more extended distal gastrectomy (ie, more than the antrum is resected). The Billroth II reconstruction has an afferent limb from the duodenum and an efferent limb extending distally. For a Billroth II reconstruction, the jejunal anastomosis can be performed in an antecolic or retrocolic, isoperistaltic, or antiperistaltic fashion  (
         <a class="graphic graphic_figure graphicRef80302" href="/z/d/graphic/80302.html" rel="external">
          figure 15
         </a>
         ). Functional differences between these have not been documented. Modification to the original Billroth II reconstruction include adding a Braun enteroenterostomy  (
         <a class="graphic graphic_figure graphicRef103470" href="/z/d/graphic/103470.html" rel="external">
          figure 16
         </a>
         ) to divert a significant amount of bile from the remnant stomach [
         <a href="#rid55">
          55
         </a>
         ].
        </p>
        <p>
         Following Billroth II reconstruction, patients can expect to suffer from alkaline reflux gastritis and some dumping  (
         <a class="graphic graphic_table graphicRef89212" href="/z/d/graphic/89212.html" rel="external">
          table 4
         </a>
         ), but unlike Billroth I reconstruction, Billroth II also leads to some degree of malabsorption, particularly of fat-soluble vitamins, because of loss of duodenal continuity. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465973149">
         <span class="h2">
          Roux-en-Y gastrojejunostomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The Roux-en-Y gastrojejunostomy anastomoses the remnant stomach to an isoperistaltic roux limb of jejunum  (
         <a class="graphic graphic_figure graphicRef89669" href="/z/d/graphic/89669.html" rel="external">
          figure 8
         </a>
         ). The proximal jejunum is anastomosed to the distal Roux limb in an end-to-side fashion. The optimal length of the afferent limb appears to be approximately 40 cm [
         <a href="#rid56">
          56,57
         </a>
         ]. A shorter limb would increase the risk of bile (alkaline) reflux gastritis, and longer limb may increase the risk of Roux stasis syndrome. An "uncut" version of the Roux-en-Y reconstruction may reduce the incidence of both bile reflux and Roux-stasis syndrome [
         <a href="#rid58">
          58-60
         </a>
         ]. Another modification to the Roux-en-Y reconstruction is double-tract reconstruction described above. (See
         <a class="local">
          'Proximal gastrectomy'
         </a>
         above.)
        </p>
        <p>
         Roux-en-Y gastrojejunostomy can be used in the same situations as a Billroth II, although it does not preserve duodenal or jejunal continuity. Roux-en-Y reconstruction diverts the bilious drainage away from the gastric remnant. Although patients suffer from lesser degrees of reflux than seen in Billroth reconstruction (I or II), patients report dumping to a greater or lesser extent [
         <a href="#rid61">
          61
         </a>
         ]. However, Roux-en-Y reconstruction may lead to gastric atony, and this, together with the adverse effect of jejunal transection, contributes to a syndrome of abdominal pain and vomiting known as the "Roux syndrome" or "Roux stasis syndrome." Patients with severe Roux stasis syndrome may require completion gastrectomy.
         <strong>
         </strong>
         (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
         <strong>
         </strong>
        </p>
        <p class="headingAnchor" id="H182355576">
         <span class="h2">
          Choice of reconstruction
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many factors influence the choice of reconstruction after gastrectomy. For most partial gastrectomy patients, we suggest a primary Roux-en-Y reconstruction. Based upon randomized trials, Roux-en-Y reconstruction appears to be tolerated better overall and leads to a better quality of life compared with Billroth reconstruction (Billroth I or Billroth II).
        </p>
        <p>
         Whether to preferentially perform a Roux-en-Y in patients whose anatomy supports a Billroth I or Billroth II, or convert to a Roux-en-Y only if complications occur, remains controversial.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a 2022 systematic review and meta-analysis of 10 randomized trials comparing at least two of the reconstruction techniques following distal gastrectomy for cancer, all five major techniques (Billroth I, Billroth II, Billroth II with Braun, Roux-en-Y reconstruction, and uncut Roux-en-Y) were considered safe, with comparable anastomotic leak, anastomotic stricture, and overall morbidity rates [
         <a href="#rid62">
          62
         </a>
         ]. At 12 months, Roux-en-Y reconstruction is associated with a reduced risk of remnant gastritis and a trend toward a reduced risk of bile reflux and esophagitis [
         <a href="#rid62">
          62
         </a>
         ]. Another meta-analysis of 12 randomized trials also concluded that Roux-en-Y reconstruction reduces remnant gastritis compared with either Billroth reconstruction, but it is also the most technically complex to perform [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A Cochrane review of eight randomized trials comparing Billroth I with Roux-en-Y reconstruction after distal gastrectomy for cancer found a lower incidence of bile reflux with Roux-en-Y but lower morbidity and shorter hospital stay with Billroth I reconstruction. However, the overall quality-of-life scores did not differ between the two techniques [
         <a href="#rid64">
          64
         </a>
         ]. All of the studies included in this review were from Asian countries. The applicability of these data to Western patients may be limited. Billroth I surgeries are limited to small, early, and quite distal lesions, which would be rare entities in the North American and European patient populations. Furthermore, Billroth I surgeries were done commonly in the ulcer surgery era but are rarely needed for benign gastric surgery currently. Thus, fewer Western surgeons may have real case experience with this procedure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective comparative study of 1300 distal gastrectomies performed for cancer, Billroth I reconstruction was associated with the least amount of weight and nutritional loss at one-year follow-up [
         <a href="#rid65">
          65
         </a>
         ]. Compared with Billroth I, Billroth II was associated with decreased body mass index and low protein and albumin, whereas Roux-en-Y was associated with decreased body mass index and low cholesterol. Other factors varied between the groups in this study, including use of open versus laparoscopic approach, extent of lymph node dissection, and final tumor stage. Thus, the results may not purely be a reflection of surgical choice but a composite of tumor, surgical, and patient factors.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective study that followed 459 patients for five years after distal gastrectomy for cancer, Roux-en-Y reconstruction was associated with lower incidence of bile reflux and gastritis, and higher incidence of gallstone formation than Billroth I reconstruction [
         <a href="#rid66">
          66
         </a>
         ]. The incidence of gastric residue was more common after Roux-en-Y reconstruction at one and two years, but the difference became less significant at five years.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465971605">
         <span class="h1">
          POSTOPERATIVE CARE AND FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Enhanced recovery after surgery (ERAS), also known as fast-track protocols, has been used for selected patients undergoing gastric surgery
         <strong>
         </strong>
         [
         <a href="#rid67">
          67,68
         </a>
         ].
         <strong>
         </strong>
         Patients with American Society of Anesthesiology (ASA) grade &gt;2 malnutrition are not candidates. The elements of a fast-track protocol are reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/113724.html" rel="external">
          "Anesthetic management for enhanced recovery after major noncardiac surgery (ERAS)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H386380145">
         <span class="h2">
          Nasogastric tube decompression
         </span>
         <span class="headingEndMark">
          —
         </span>
         Routine nasogastric decompression is not necessary, even for patients undergoing esophageal or gastric surgery. For most patients with a nasogastric tube, it can be discontinued in the recovery room or on the first day postoperatively [
         <a href="#rid16">
          16
         </a>
         ]. If a nasogastric tube becomes dislodged or has fallen out, it should not be replaced unless that patient has symptoms.
        </p>
        <p>
         Some patients may have prolonged spasm or edema of the gastrojejunal or jejunojejunal anastomoses leading to nausea and emesis. If the gastrointestinal decompression has been discontinued, a nasogastric tube may need to be replaced.
        </p>
        <p>
         When nasogastric replacement is needed following proximal subtotal gastrectomy, we prefer placement under fluoroscopy to avoid any risk of disrupting the proximal anastomosis; for distal gastrectomy, fluoroscopic imaging may not be necessary.
        </p>
        <p class="headingAnchor" id="H465973195">
         <span class="h2">
          Perioperative nutritional support
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to gastric resection, patients can have poor oral intake due to nausea, vomiting, or early satiety and may be malnourished, increasing the risk for surgical complications. After gastric surgery, some patients may not be able to resume oral intake due to spasm or edema of the gastrojejunal or jejunojejunal anastomoses. In the setting of preoperative malnutrition, perioperative nutritional support should be provided, which can be initiated via total
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         (TPN) or a feeding jejunostomy placed at the time of the gastric resection [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
         If a feeding jejunostomy tube is to be used, it should be placed into the jejunum approximately 30 to 40 cm beyond the most distal anastomosis. The tube should be flushed twice daily for the first 24 hours, and thereafter, it can be used to provide enteral support. Enteral feedings can be initiated as a dilute solution at approximately 10 mL per hour and increased to the target rate.
        </p>
        <p>
         There may be a role for preoperative nutritional support if the patient's nutritional indices are severely depressed. (See
         <a class="medical medical_review" href="/z/d/html/2880.html" rel="external">
          "Overview of perioperative nutrition support", section on 'Preoperative nutrition support'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465972173">
         <span class="h2">
          Postgastrectomy diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         The extent of alteration of oral intake will be determined by the size of the gastric remnant and the need to conservatively manage postgastrectomy syndromes. Small frequent meals, high in protein and inclusive of fat, should be consumed approximately six times per day. Liquids may need to be taken separately from solids. Meals high in simple carbohydrates can contribute to dumping syndrome and may need to be avoided. The patient should be followed closely, at least initially, by a dietician experienced with managing patients who have undergone this procedure.
        </p>
        <p>
         Vitamin and mineral supplementation may also be necessary (see
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management"
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who have undergone subtotal gastrectomy will need
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         supplementation. (See
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who have undergone reconstructive procedures that bypass the duodenum (eg, Billroth II, Roux-en-Y) may require supplementation of fat-soluble vitamins (A, D, E, K). (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2033.html" rel="external">
          "Overview of vitamin D"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2624.html" rel="external">
          "Overview of vitamin K"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Calcium and iron should also be supplemented. (See
         <a class="medical medical_review" href="/z/d/html/7148.html" rel="external">
          "Treatment of iron deficiency anemia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/826.html" rel="external">
          "Treatment of hypocalcemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H465972182">
         <span class="h2">
          Follow-up
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following partial gastric resection, the patient should follow up to evaluate the incision(s) and overall recovery and periodically thereafter to monitor weight, nutritional status, and the presence of any symptoms that may indicate the development of complications related to the gastric resection or reconstruction.
        </p>
        <p>
         Symptoms may include weight loss, fever, abdominal pain, early satiety, persistent vomiting, reflux symptoms, hematemesis, and/or unexplained anemia. Further abdominal imaging or endoscopic evaluation may be needed. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/676.html" rel="external">
          "Endoscopic retrograde cholangiopancreatography (ERCP) after Billroth II reconstruction"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15864.html" rel="external">
          "ERCP in patients with Roux-en-Y anatomy"
         </a>
         .)
        </p>
        <p>
         Following gastric resection for malignancy, scheduled follow-up is suggested to detect clinical symptoms of recurrence, which occurs most commonly in the first two to three years. However, it is important to note that most patients undergoing partial gastrectomy for adenocarcinoma do not fail surgical treatment due to gastric mucosal recurrence but rather develop nodal disease or distant metastases [
         <a href="#rid70">
          70
         </a>
         ]. These issues are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Post-treatment surveillance'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H133457468">
         <span class="h1">
          PERIOPERATIVE MORTALITY AND MORBIDITIES
         </span>
        </p>
        <p class="headingAnchor" id="H2185932688">
         <span class="h2">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Perioperative mortality following partial gastric resection is low, even among appropriately selected candidates with malignant tumor. In series comparing open with laparoscopic gastric resection, no significant differences have been found, and reported perioperative mortality rates in contemporary series are 1 to 2 percent [
         <a href="#rid71">
          71,72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2284906312">
         <span class="h2">
          Morbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         In similar contemporary series, the morbidity rate varies from 18 to 26 percent, depending on the inclusion criteria and length of follow-up [
         <a href="#rid71">
          71,72
         </a>
         ]. Complications following partial gastrectomy can be anatomic, related to the extent of gastric resection and the type of reconstruction, or physiologic, related to the loss of function in the section of stomach removed  (
         <a class="graphic graphic_table graphicRef89212" href="/z/d/graphic/89212.html" rel="external">
          table 4
         </a>
         ). Postgastrectomy complications are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2141605465">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/134311.html" rel="external">
          "Society guideline links: Gastric surgery for cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H465971590">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Partial gastric resection is used to treat most cases of benign gastric disease for which resection is indicated (eg, ulcer disease, benign tumor, traumatic injury); malignant gastric tumors, such as adenocarcinoma, where sufficient margins can be achieved; in select cases of gastrointestinal stromal tumor (GIST); some neuroendocrine tumors; and complications related to treatment of lymphoma. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Surgical techniques
         </strong>
         – Partial gastrectomy procedures include wedge resection, sleeve resection, antrectomy/distal gastrectomy, subtotal gastrectomy, proximal gastrectomy, and pylorus-preserving gastrectomy. The extent of gastric resection and type of reconstruction chosen is determined by the location, nature, and extent of disease and impacts the nature of perioperative and later complications, particularly the development of postgastrectomy syndromes  (
         <a class="graphic graphic_algorithm graphicRef141463" href="/z/d/graphic/141463.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Resection techniques'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Margins
         </strong>
         – For patients undergoing partial gastrectomy for non-early gastric adenocarcinoma, we obtain a margin of at least 3 cm for tumors with an expansive growth pattern and at least 5 cm for tumors with an infiltrative growth pattern. A proximal margin of 2 cm is sufficient for early gastric cancer. Intraoperative frozen sections of the proximal and distal margins should be obtained to determine if a wider excision is necessary. (See
         <a class="local">
          'Optimal surgical margin'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Reconstruction
         </strong>
         – Several reconstructions are used to restore gastrointestinal continuity following partial gastrectomy. The most common are the Billroth I, Billroth II, and Roux-en-Y reconstructions, with the choice between these depending upon the remnant anatomy available for reconstruction. For patients who have undergone partial gastrectomy, we suggest Roux-en-Y reconstruction over Billroth reconstruction (Billroth I or Billroth II) (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Gastrointestinal reconstruction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Function-preserving alternatives
         </strong>
         – Function-preserving techniques for partial gastrectomy have been introduced by Japanese surgeons to limit or avoid postgastrectomy syndromes in patients. These include proximal gastrectomy for early gastric cancers in the upper stomach and pylorus-preserving gastrectomy for early gastric cancers in the middle third of the stomach. However, these operations should only be performed by experienced surgeons in select patients with early gastric cancer. (See
         <a class="local">
          'Function-preserving partial gastrectomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Open versus minimally invasive surgery
         </strong>
         – A laparoscopic approach may be most feasible for limited gastric resections that require minimal dissection, such as wedge or sleeve resection for benign indications or gastrointestinal stromal tumor. At high-volume centers in Asia and Europe, the feasibility and oncologic safety of laparoscopic partial gastrectomy for both early and locally advanced gastric cancer has been demonstrated by many randomized trials. (See
         <a class="local">
          'Open versus laparoscopic partial gastrectomy'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/109436.html" rel="external">
          "Laparoscopic gastrectomy for cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postoperative care
         </strong>
         – Nasogastric tube, if placed, can be removed on the day of or after the surgery. Patients should be started on a postgastrectomy diet (small, frequent meals) and vitamin supplements. Those who are malnourished preoperatively may require nutritional supplement with parenteral or jejunostomy feeding. Following partial gastrectomy for malignancy, scheduled follow-up is suggested to evaluate for recurrence. (See
         <a class="local">
          'Follow-up'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer", section on 'Post-treatment surveillance'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Outcomes
         </strong>
         – In contemporary series, partial gastrectomy carries a mortality rate of 1 to 2 percent and a morbidity rate of 18 to 26 percent. Complications following partial gastrectomy can be related to anatomic or physiologic alterations. The most concerning postoperative complication is anastomotic leak. The nature and severity of postgastrectomy syndromes depend upon the extent of gastric resection and the type of gastric reconstruction  (
         <a class="graphic graphic_table graphicRef89212" href="/z/d/graphic/89212.html" rel="external">
          table 4
         </a>
         ). (See
         <a class="local">
          'Morbidities'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/89634.html" rel="external">
          "Postgastrectomy complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2837558406">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Debrah Wirtzfeld, MD, MSc, FRCSC, FACS, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Soybel DI. Anatomy and physiology of the stomach. Surg Clin North Am 2005; 85:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition). Gastric Cancer 2023; 26:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang Z, Liu C, Cai Z, et al. Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis. Cancer Control 2021; 28:10732748211043665.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li GZ, Doherty GM, Wang J. Surgical Management of Gastric Cancer: A Review. JAMA Surg 2022; 157:446.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischbach W. MALT lymphoma: forget surgery? Dig Dis 2013; 31:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischbach W. Long-term follow-up of gastric lymphoma after stomach conserving treatment. Best Pract Res Clin Gastroenterol 2010; 24:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischbach W, Schramm S, Goebeler E. Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol 2011; 49:430.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdel Khalek M, Joshi V, Kandil E. Robotic-assisted laparoscopic wedge resection of a gastric leiomyoma with intraoperative ultrasound localization. Minim Invasive Ther Allied Technol 2011; 20:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boulanger-Gobeil C, Gagné JP, Julien F, et al. Laparoscopic Intragastric Resection: An Alternative Technique for Minimally Invasive Treatment of Gastric Submucosal Tumors. Ann Surg 2018; 267:e12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ito M, Onozawa H, Saito M, et al. Laparoscopic total gastrectomy performed for juvenile polyposis of the stomach: A case report. Int J Surg Case Rep 2022; 97:107368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol 2016; 17:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lordick F, Carneiro F, Cascinu S, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol 2022; 33:1005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coburn N, Cosby R, Klein L, et al. Staging and surgical approaches in gastric cancer: a clinical practice guideline. Curr Oncol 2017; 24:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon M, Cardoso R, Tinmouth J, et al. What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel. Gastric Cancer 2014; 17:377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holthöfer H. Ontogeny of cell type-specific enzyme reactivities in kidney collecting ducts. Pediatr Res 1987; 22:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mortensen K, Nilsson M, Slim K, et al. Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Br J Surg 2014; 101:1209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koh YX, Chok AY, Zheng HL, et al. A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach. Ann Surg Oncol 2013; 20:3549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hakkenbrak NAG, Jansma EP, van der Wielen N, et al. Laparoscopic versus open distal gastrectomy for gastric cancer: A systematic review and meta-analysis. Surgery 2022; 171:1552.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen JD, Yang XP, Shen JG, et al. Prognostic improvement of reexcision for positive resection margins in patients with advanced gastric cancer. Eur J Surg Oncol 2013; 39:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spicer J, Benay C, Lee L, et al. Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma. Ann Surg Oncol 2014; 21:2580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021; 41:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim TH, Kim IH, Kang SJ, et al. Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach. J Gastric Cancer 2023; 23:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyashiro I, Hiratsuka M, Kishi K, et al. Intraoperative diagnosis using sentinel node biopsy with indocyanine green dye in gastric cancer surgery: an institutional trial by experienced surgeons. Ann Surg Oncol 2013; 20:542.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyashiro I. What is the problem in clinical application of sentinel node concept to gastric cancer surgery? J Gastric Cancer 2012; 12:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang Y, Pan M, Deng Z, et al. How useful is sentinel lymph node biopsy for the status of lymph node metastasis in cT1N0M0 gastric cancer? A systematic review and meta-analysis. Updates Surg 2021; 73:1275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Takeuchi H, Kitagawa Y. Sentinel lymph node biopsy in gastric cancer. Cancer J 2015; 21:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lianos GD, Bali CD, Hasemaki N, et al. Sentinel Node Navigation in Gastric Cancer: Where Do We Stand? J Gastrointest Cancer 2019; 50:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cardoso R, Bocicariu A, Dixon M, et al. What is the accuracy of sentinel lymph node biopsy for gastric cancer? A systematic review. Gastric Cancer 2012; 15 Suppl 1:S48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyashiro I, Hiratsuka M, Sasako M, et al. High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer 2014; 17:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kitagawa Y, Takeuchi H, Takagi Y, et al. Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol 2013; 31:3704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           An JY, Min JS, Hur H, et al. Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA). Br J Surg 2020; 107:1429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Booka E, Takeuchi H. Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer. J Gastric Cancer 2023; 23:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beyer K. Surgery Matters: Progress in Surgical Management of Gastric Cancer. Curr Treat Options Oncol 2023; 24:108.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhao L, Ling R, Chen J, et al. Clinical Outcomes of Proximal Gastrectomy versus Total Gastrectomy for Proximal Gastric Cancer: A Systematic Review and Meta-Analysis. Dig Surg 2021; 38:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamasaki M, Takiguchi S, Omori T, et al. Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer. Gastric Cancer 2021; 24:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kosuga T, Ichikawa D, Komatsu S, et al. Feasibility and Nutritional Benefits of Laparoscopic Proximal Gastrectomy for Early Gastric Cancer in the Upper Stomach. Ann Surg Oncol 2015; 22 Suppl 3:S929.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ushimaru Y, Fujiwara Y, Shishido Y, et al. Clinical Outcomes of Gastric Cancer Patients Who Underwent Proximal or Total Gastrectomy: A Propensity Score-Matched Analysis. World J Surg 2018; 42:1477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaibu Z, Chen Z, Mzee SAS, et al. Effects of reconstruction techniques after proximal gastrectomy: a systematic review and meta-analysis. World J Surg Oncol 2020; 18:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fu J, Li Y, Liu X, et al. Clinical outcomes of proximal gastrectomy with gastric tubular reconstruction and total gastrectomy for proximal gastric cancer: A matched cohort study. Front Surg 2022; 9:1052643.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuroda S, Choda Y, Otsuka S, et al. Multicenter retrospective study to evaluate the efficacy and safety of the double-flap technique as antireflux esophagogastrostomy after proximal gastrectomy (rD-FLAP Study). Ann Gastroenterol Surg 2019; 3:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kano Y, Ohashi M, Ida S, et al. Laparoscopic proximal gastrectomy with double-flap technique versus laparoscopic subtotal gastrectomy for proximal early gastric cancer. BJS Open 2020; 4:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamashita Y, Yamamoto A, Tamamori Y, et al. Side overlap esophagogastrostomy to prevent reflux after proximal gastrectomy. Gastric Cancer 2017; 20:728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamashita Y, Tatsubayashi T, Okumura K, et al. Modified side overlap esophagogastrostomy after laparoscopic proximal gastrectomy. Ann Gastroenterol Surg 2022; 6:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang S, Lin S, Wang H, et al. Reconstruction methods after radical proximal gastrectomy: A systematic review. Medicine (Baltimore) 2018; 97:e0121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hipp J, Hillebrecht HC, Kalkum E, et al. Systematic review and meta-analysis comparing proximal gastrectomy with double-tract-reconstruction and total gastrectomy in gastric and gastroesophageal junction cancer patients: Still no sufficient evidence for clinical decision-making. Surgery 2023; 173:957.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park DJ, Han SU, Hyung WJ, et al. Effect of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction vs Total Gastrectomy on Hemoglobin Level and Vitamin B12 Supplementation in Upper-Third Early Gastric Cancer: A Randomized Clinical Trial. JAMA Netw Open 2023; 6:e2256004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang SH, Park DJ, Kim HH, et al. Short-Term Outcomes of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction Versus Laparoscopic Total Gastrectomy for Upper Early Gastric Cancer: A KLASS 05 Randomized Clinical Trial. J Gastric Cancer 2022; 22:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mao X, Xu X, Zhu H, et al. A comparison between pylorus-preserving and distal gastrectomy in surgical safety and functional benefit with gastric cancer: a systematic review and meta-analysis. World J Surg Oncol 2020; 18:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park DJ, Kim YW, Yang HK, et al. Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial). Br J Surg 2021; 108:1043.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jin T, Chen ZH, Liang PP, et al. A Gastrectomy for early-stage gastric cancer patients with or without preserving celiac branches of vagus nerves: A meta-analysis. Surgery 2023; 173:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang Y, Yang F, Ma J, et al. Surgical and oncological outcomes of distal gastrectomy compared to total gastrectomy for middle-third gastric cancer: A systematic review and meta-analysis. Oncol Lett 2022; 24:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kong L, Yang N, Shi L, et al. Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials. Onco Targets Ther 2016; 9:6795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Z, Bai B, Xie F, Zhao Q. Distal versus total gastrectomy for middle and lower-third gastric cancer: A systematic review and meta-analysis. Int J Surg 2018; 53:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SS, Chung HY, Kwon OK, Yu W. Long-term Quality of Life After Distal Subtotal and Total Gastrectomy: Symptom- and Behavior-oriented Consequences. Ann Surg 2016; 263:738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cui LH, Son SY, Shin HJ, et al. Billroth II with Braun Enteroenterostomy Is a Good Alternative Reconstruction to Roux-en-Y Gastrojejunostomy in Laparoscopic Distal Gastrectomy. Gastroenterol Res Pract 2017; 2017:1803851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burden WR, Hodges RP, Hsu M, O'Leary JP. Alkaline reflux gastritis. Surg Clin North Am 1991; 71:33.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gustavsson S, Ilstrup DM, Morrison P, Kelly KA. Roux-Y stasis syndrome after gastrectomy. Am J Surg 1988; 155:490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jangjoo A, Mehrabi Bahar M, Aliakbarian M. Uncut Roux-en-y esophagojejunostomy: A new reconstruction technique after total gastrectomy. Indian J Surg 2010; 72:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiao YJ, Lu TT, Liu DM, et al. Comparison between laparoscopic uncut Roux-en-Y and Billroth II with Braun anastomosis after distal gastrectomy: A meta-analysis. World J Gastrointest Surg 2022; 14:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Y, Wang Q, Yang KL, et al. Uncut Roux-en-Y might reduce the rate of reflux gastritis after radical distal gastrectomy: An evidence mapping from a systematic review. Int J Surg 2022; 97:106184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El Halabi HM, Lawrence W Jr. Clinical results of various reconstructions employed after total gastrectomy. J Surg Oncol 2008; 97:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lombardo F, Aiolfi A, Cavalli M, et al. Techniques for reconstruction after distal gastrectomy for cancer: updated network meta-analysis of randomized controlled trials. Langenbecks Arch Surg 2022; 407:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiang H, Li Y, Wang T. Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis. Cir Esp (Engl Ed) 2021; 99:412.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nishizaki D, Ganeko R, Hoshino N, et al. Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer. Cochrane Database Syst Rev 2021; 9:CD012998.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim YN, Choi YY, An JY, et al. Comparison of Postoperative Nutritional Status after Distal Gastrectomy for Gastric Cancer Using Three Reconstructive Methods: a Multicenter Study of over 1300 Patients. J Gastrointest Surg 2020; 24:1482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu CH, Huang KH, Chen MH, et al. Comparison of the Long-term Outcome Between Billroth-I and Roux-en-Y Reconstruction Following Distal Gastrectomy for Gastric Cancer. J Gastrointest Surg 2021; 25:1955.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen S, Zou Z, Chen F, et al. A meta-analysis of fast track surgery for patients with gastric cancer undergoing gastrectomy. Ann R Coll Surg Engl 2015; 97:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li YJ, Huo TT, Xing J, et al. Meta-analysis of efficacy and safety of fast-track surgery in gastrectomy for gastric cancer. World J Surg 2014; 38:3142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ireland P, Jaunoo S. Feeding jejunostomy in upper gastrointestinal resections: a UK-wide survey. Ann R Coll Surg Engl 2020; 102:697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jiao X, Wang Y, Wang F, Wang X. Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy. Medicine (Baltimore) 2020; 99:e23795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurita N, Miyata H, Gotoh M, et al. Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System. Ann Surg 2015; 262:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watanabe M, Miyata H, Gotoh M, et al. Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database. Ann Surg 2014; 260:1034.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15161 Version 19.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16139026" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Anatomy and physiology of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36342574" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34569315" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Impact of Surgical Margin Status on Survival in Gastric Cancer: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35319717" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Surgical Management of Gastric Cancer: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23797121" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : MALT lymphoma: forget surgery?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20206110" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Long-term follow-up of gastric lymphoma after stomach conserving treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21476178" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21919811" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Robotic-assisted laparoscopic wedge resection of a gastric leiomyoma with intraoperative ultrasound localization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27926576" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Laparoscopic Intragastric Resection: An Alternative Technique for Minimally Invasive Treatment of Gastric Submucosal Tumors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35841758" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Laparoscopic total gastrectomy performed for juvenile polyposis of the stomach: A case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26822397" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35914639" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29089800" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Staging and surgical approaches in gastric cancer: a clinical practice guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23633230" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : What studies are appropriate and necessary for staging gastric adenocarcinoma? Results of an international RAND/UCLA expert panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2825108" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Ontogeny of cell type-specific enzyme reactivities in kidney collecting ducts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25047143" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Consensus guidelines for enhanced recovery after gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23793362" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : A systematic review and meta-analysis comparing laparoscopic versus open gastric resections for gastrointestinal stromal tumors of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35101328" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Laparoscopic versus open distal gastrectomy for gastric cancer: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23164622" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prognostic improvement of reexcision for positive resection margins in patients with advanced gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24806114" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34197702" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36750993" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22941164" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Intraoperative diagnosis using sentinel node biopsy with indocyanine green dye in gastric cancer surgery: an institutional trial by experienced surgeons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22500258" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : What is the problem in clinical application of sentinel node concept to gastric cancer surgery?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33723712" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : How useful is sentinel lymph node biopsy for the status of lymph node metastasis in cT1N0M0 gastric cancer? A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25611776" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Sentinel lymph node biopsy in gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30815770" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Sentinel Node Navigation in Gastric Cancer: Where Do We Stand?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22262403" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : What is the accuracy of sentinel lymph node biopsy for gastric cancer? A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23933782" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24019550" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32492186" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Laparoscopic sentinel node navigation surgery versus laparoscopic gastrectomy with lymph node dissection for early gastric cancer: short-term outcomes of a multicentre randomized controlled trial (SENORITA).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36750996" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36656504" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Surgery Matters: Progress in Surgical Management of Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33152740" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Clinical Outcomes of Proximal Gastrectomy versus Total Gastrectomy for Proximal Gastric Cancer: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33118118" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Multicenter prospective trial of total gastrectomy versus proximal gastrectomy for upper third cT1 gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25986867" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Feasibility and Nutritional Benefits of Laparoscopic Proximal Gastrectomy for Early Gastric Cancer in the Upper Stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29058068" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Clinical Outcomes of Gastric Cancer Patients Who Underwent Proximal or Total Gastrectomy: A Propensity Score-Matched Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32677956" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Effects of reconstruction techniques after proximal gastrectomy: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36713677" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Clinical outcomes of proximal gastrectomy with gastric tubular reconstruction and total gastrectomy for proximal gastric cancer: A matched cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30697614" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Multicenter retrospective study to evaluate the efficacy and safety of the double-flap technique as antireflux esophagogastrostomy after proximal gastrectomy (rD-FLAP Study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32207570" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Laparoscopic proximal gastrectomy with double-flap technique versus laparoscopic subtotal gastrectomy for proximal early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27942874" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Side overlap esophagogastrostomy to prevent reflux after proximal gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35847432" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Modified side overlap esophagogastrostomy after laparoscopic proximal gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29538208" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Reconstruction methods after radical proximal gastrectomy: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36543733" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Systematic review and meta-analysis comparing proximal gastrectomy with double-tract-reconstruction and total gastrectomy in gastric and gastroesophageal junction cancer patients: Still no sufficient evidence for clinical decision-making.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36790808" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction vs Total Gastrectomy on Hemoglobin Level and Vitamin B12 Supplementation in Upper-Third Early Gastric Cancer: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35534447" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Short-Term Outcomes of Laparoscopic Proximal Gastrectomy With Double-Tract Reconstruction Versus Laparoscopic Total Gastrectomy for Upper Early Gastric Cancer: A KLASS 05 Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32641052" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : A comparison between pylorus-preserving and distal gastrectomy in surgical safety and functional benefit with gastric cancer: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34487147" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36379744" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : A Gastrectomy for early-stage gastric cancer patients with or without preserving celiac branches of vagus nerves: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35949603" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Surgical and oncological outcomes of distal gastrectomy compared to total gastrectomy for middle-third gastric cancer: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27853375" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Total versus subtotal gastrectomy for distal gastric cancer: meta-analysis of randomized clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29602012" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Distal versus total gastrectomy for middle and lower-third gastric cancer: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26501699" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Long-term Quality of Life After Distal Subtotal and Total Gastrectomy: Symptom- and Behavior-oriented Consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28163716" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Billroth II with Braun Enteroenterostomy Is a Good Alternative Reconstruction to Roux-en-Y Gastrojejunostomy in Laparoscopic Distal Gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1989108" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Alkaline reflux gastritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3344916" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Roux-Y stasis syndrome after gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23133254" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Uncut Roux-en-y esophagojejunostomy: A new reconstruction technique after total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35979420" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Comparison between laparoscopic uncut Roux-en-Y and Billroth II with Braun anastomosis after distal gastrectomy: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34861427" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Uncut Roux-en-Y might reduce the rate of reflux gastritis after radical distal gastrectomy: An evidence mapping from a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17963246" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Clinical results of various reconstructions employed after total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35094151" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Techniques for reconstruction after distal gastrectomy for cancer: updated network meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34130813" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Comparison of Billroth I, Billroth II, and Roux-en-Y reconstructions following distal gastrectomy: A systematic review and network meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34523717" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Roux-en-Y versus Billroth-I reconstruction after distal gastrectomy for gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31309380" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Comparison of Postoperative Nutritional Status after Distal Gastrectomy for Gastric Cancer Using Three Reconstructive Methods: a Multicenter Study of over 1300 Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33205309" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Comparison of the Long-term Outcome Between Billroth-I and Roux-en-Y Reconstruction Following Distal Gastrectomy for Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25519256" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : A meta-analysis of fast track surgery for patients with gastric cancer undergoing gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25228170" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Meta-analysis of efficacy and safety of fast-track surgery in gastrectomy for gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32735118" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Feeding jejunostomy in upper gastrointestinal resections: a UK-wide survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33371151" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Recurrence pattern and its predictors for advanced gastric cancer after total gastrectomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25719804" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Risk Model for Distal Gastrectomy When Treating Gastric Cancer on the Basis of Data From 33,917 Japanese Patients Collected Using a Nationwide Web-based Data Entry System.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25072429" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Total gastrectomy risk model: data from 20,011 Japanese patients in a nationwide internet-based database.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
